Loading insider details...
Beta
Latest Form 4 (Jun 26, 2026): Grant/Award of 30,000 SPRY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 26, 2026 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 30,000 | n/a |
| Jan 5, 2026 | Design Therapeutics, Inc. (DSGN) | Grant/Award | 750,000 | n/a |
| Dec 11, 2025 | Design Therapeutics, Inc. (DSGN) | Grant/Award | 525,000 | n/a |
| Nov 14, 2025 | ARS Pharmaceuticals, Inc. (SPRY) | Gift | 250,000 | n/a |
| Jun 27, 2025 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 30,000 | n/a |
| Jan 7, 2025 | Design Therapeutics, Inc. (DSGN) | Grant/Award | 600,000 | n/a |
| Jun 24, 2024 | ARS Pharmaceuticals, Inc. (SPRY) | Grant/Award | 40,000 | n/a |
| Jun 17, 2024 | ARS Pharmaceuticals, Inc. (SPRY) | Gift | 200,000 | n/a |
| Jun 8, 2024 | ARS Pharmaceuticals, Inc. (SPRY) | Gift | 1,332,950 | n/a |
| Jun 6, 2024 | ARS Pharmaceuticals, Inc. (SPRY) | Other (see footnotes) | 2,665,800 | n/a |